Neoplasia/BPH

	A phase-specific benefit-toxicity framework for perioperative trials in muscle-invasive bladder cancer: A focused review andtrial-level mapping analysis. Urol Oncol Shinohara M, Narita T, Hamaya T, Ichiyama T, Fujita N, Okamoto T, Yamamoto H, Ohyama C, Hatakeyama S. PMID: 42632293 [PubMed - as supplied by publisher]
	miR-638 Upregulation in Serum and Tissues Functions as a Diagnostic and Prognostic Biomarker and Facilitates Prostate Cancer Progression. Urol Oncol Wang L, Yang H, Wang J. PMID: 42632292 [PubMed - as supplied by publisher]
	Clinical characteristics, treatment patterns, and survival outcomes in ductal prostate cancer: a multicenter retrospective analysis. World J Urol Handke A, Paffenholz P, Schlack K, Seifert KE, Linxweiler J, Mink J, Flockerzi F, Nestler T, Wenzel M, Siech C, Darr C, Grünwald V, Roghmann F, Tully KH. PMID: 42631874 [PubMed - indexed for MEDLINE]
	Non-invasive neuromodulation for LUTS in Parkinson's disease: a comprehensive systematic review and meta-analysis of tibial nerve stimulation with GRADE evaluation. Acta Neurol Belg Abo-Elsoad MF, Abbas AW, Abou Elezz AM, Abo Zaid M, Ahmed AN, Hewezy O, Talkhan A. PMID: 42631842 [PubMed - as supplied by publisher]
	The Intersection of Religiosity, Perceived Discrimination, and Psychological Well-Being in a Racially and Ethnically Diverse Sample of Male Cancer Survivors. Cancer Control Murphy A, Fletcher-Duncan A, Cherell CD, Li X, Fan W, Jacobs KL, Denis J, Lezama C, Bethune B, Hu B, Gonzalez BD, Green BL. PMID: 42631521 [PubMed - indexed for MEDLINE]
	Optimizing Sequential Decision Rules for Prostate Cancer Biopsy Management: A Multi-Objective Statistical Framework. J Am Stat Assoc Qiu J, Zhao YQ, Wei J, Chinnaiyan AM, Tosoian J, Zheng Y. PMID: 42631260 [PubMed]
	A retrospective cohort study on the improvement of urodynamic parameters and NIH-CPSI scores with Relin granules in BPH patients with high prostatitis-like symptom scores. Am J Transl Res Xu X, Qu J, Hu X. PMID: 42631160 [PubMed]
	Mitochondrial Dysfunction in Renal Cell Carcinoma: A Comprehensive Review of Pathogenic Mechanisms and Emerging Therapeutic Opportunities. Oncol Res Wang Y, Liu J, Xu Q, Ma Z. PMID: 42630702 [PubMed - indexed for MEDLINE]
	Combining PSA density and imaging data with transcript markers from urinary cells to improve prediction of prostate cancer reclassification in patients on active surveillance. BJUI Compass Borkowetz A, Gräfe S, Kwe J, Fuessel S, Thomas C, Erdmann K. PMID: 42630620 [PubMed]
	Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study. Ther Adv Med Oncol Bimbatti D, Nasso C, Aspden D, Buti S, Antonj L, Signori A, Verzoni E, Lolli C, Di Napoli M, Fanelli M, De Lucia M, Masini C, Roviello G, Arduini D, Filippi R, Mennitto A, Sorarù M, Bozza G, Formisano L, Messina C, Bonomi L, Guida A, Fantinel E, Scagliarini S, Vitale MG, Chiellino S, Maiorano BA, Deppieri FM, Zucali PA, Cavo A, Caserta C, La Russa F, Conteduca V, Maines F, Zai S, Pierantoni F, Icardi M, Rescigno P, Di Costanzo F, Banna GL, Rebuzzi SE. PMID: 42630506 [PubMed]
	Efficacy of neoadjuvant novel hormonal therapy combined with radical prostatectomy for high-risk prostate cancer and analysis of biochemical recurrence-free survival. Am J Transl Res Jiang S, Du C, Qu L, Liu L, Ren B, Luo W. PMID: 42630365 [PubMed]
	The Local Effects of Systemic Therapies in Urological Oncology: A Systematic Review. Cancer Med Nordheimer S, Gofrit ON. PMID: 42630020 [PubMed - indexed for MEDLINE]
	Prognostic and immunological value of LINC01615-related genes in kidney clear cell carcinoma: Integrated bioinformatics analysis and expression validation. Medicine (Baltimore) Guo S, Xu S, Song P, Fu J, Wang S, Xie W, Wang Y. PMID: 42629666 [PubMed - indexed for MEDLINE]
	Re: Roberto Contieri, Marco Paciotti, Alessandro Uleri, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12. Eur Urol Oncol Di Bello F, Gallioli A, Palou J, Breda A. PMID: 42629309 [PubMed - as supplied by publisher]
	Prospective Multicenter Study on the Predictive Role of Node-RADS Score in Patients With Prostate Cancer Who Are Candidates for Radical Prostatectomy: Comparative Analysis with Validated Nomograms and PET/CT Scan. Eur Urol Focus Sciarra A, Casale P, Bevilacqua G, Basile G, Santarelli V, Buffi NM, Lazzeri M, Lunghezzani G, Lucciola S, Messina E, Laschena L, Dehghanpour A, Di Pierro GB, Franco G, Del Giudice F, Gentilucci A, Dipinto P, Corvino R, Salciccia S, Magliocca FM, Panebianco V. PMID: 42629306 [PubMed - as supplied by publisher]
	No Evidence of Post-Finasteride Syndrome in 267,983 person-years follow-up in the Prostate Cancer Prevention Trial. Urology Till C, Tangen CM, Goodman P, Unger JM, Thompson IM Jr. PMID: 42628582 [PubMed - as supplied by publisher]
	Age at Diagnosis and Postoperative Outcomes Among Men Treated for Prostate Cancer in the U.S. Military Health System. Clin Genitourin Cancer Oroho MR, Dide-Agossou C, Kern SQ, Almeida AA, Darmon S, Shriver CD, Zhu K, Eaglehouse YL. PMID: 42628214 [PubMed - as supplied by publisher]
	APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial. JCO Precis Oncol Shi X, Shetty AC, Wang J, Song Y, Sutera PA, Deek MP, Patel KR, Madan RA, Tang C, Proudfoot J, Davicioni E, Hussain A, Nguyen P, Sweeney C, Boytim E, Lacuna KP, Ryan CJ, Antonarakis ES, Tran PT, Hwang J. PMID: 42628007 [PubMed - indexed for MEDLINE]
	Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity. Clin Cancer Res Zacharias NM, Rupe ES, Chen X, Kotecha RR, Rieke DT, McGregor BA, Pesquera P, Yu Z, Grover A, Daw NC, Wang E, Chan SWS, Douglas-Lindsay D, Fan AC, Knoche EM, Kyriakopoulos CE, Lalani AA, Mantia CM, Merla A, Voss MH, Pfanzelter N, Ramakrishna S, Reaume NM, Tang T, Ingram DR, Shamsutdinova D, Wani KM, Wang WL, Lazar AJ, Sheth RA, Rao P, Grimm SL, Coarfa C, He R, Qian J, Duan F, Bisht D, Chauhan PK, Perelli L, Genovese G, Yang L, Lin C, Karam JA, La Posta L, Dondossola E, Basar R, Uprety N, Rezvani K, Gao J, Wang L, Solis Soto LM, Lim B, Tannir NM, Karki M, Msaouel P. PMID: 42627757 [PubMed - as supplied by publisher]
	ASO Visual Abstract: A Pathology-Based Model for Postoperative Recurrence or Metastasis Prediction and Adjuvant Immunotherapy Implications of Clear-Cell Renal Cell Carcinoma: A Multicenter, Retrospective Study. Ann Surg Oncol Zhu Y, Ge L, Liu Z, Sun J, Wang X, Chu C, Zhao Z, Zhu Z, Shen H, Shi J, Liu G, Ji C, Zhang Q, Gan W, Zhang S, Jiang B, Guo H. PMID: 42627609 [PubMed - as supplied by publisher]

Articles 1 - 20 / 190679

Page 1 of 9534



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy